 | • レポートコード：QYR2104Z2474 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、融合タンパク質セラピー法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫グロブリン（Ig）融合タンパク質、副甲状腺ホルモン（PTH）融合タンパク質、サイトカイン組換え融合タンパク質、その他）、用途別市場規模（キメラタンパク質医薬品、生物工学、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・融合タンパク質セラピー法の市場動向 ・企業の競争状況、市場シェア ・融合タンパク質セラピー法の種類別市場規模（免疫グロブリン（Ig）融合タンパク質、副甲状腺ホルモン（PTH）融合タンパク質、サイトカイン組換え融合タンパク質、その他） ・融合タンパク質セラピー法の用途別市場規模（キメラタンパク質医薬品、生物工学、その他） ・融合タンパク質セラピー法の北米市場規模2016-2027（アメリカ、カナダ） ・融合タンパク質セラピー法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・融合タンパク質セラピー法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・融合タンパク質セラピー法の中南米市場規模2016-2027（メキシコ、ブラジル） ・融合タンパク質セラピー法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Abnova、Novus、Origene、Chimerigen、Peprotech、Prospec、Aboslute Antibody、Amgen、Abbvie、J & J、Bristol-Myers Squibb、Novartis、Merck、Alexion Pharmaceuticals、Takeda、Biogen、UCB、Eli Lilly and Company、AstraZeneca） ・結論 |
Fusion proteins or chimeric (kī-ˈmir-ik) proteins (literally, made of parts from different sources) are proteins created through the joining of two or more genes that originally coded for separate proteins.
Market Analysis and Insights: Global Fusion Protein Therapy Market
The global Fusion Protein Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fusion Protein Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fusion Protein Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fusion Protein Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fusion Protein Therapy market.
Global Fusion Protein Therapy Scope and Market Size
Fusion Protein Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fusion Protein Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Immunoglobulin (Ig) Fusion Protein
Parathyroid Hormone (PTH) Fusion Protein
Cytokines Recombinant Fusion Protein
Others
Segment by Application
Chimeric Protein Drugs
Biological Technology
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Abnova
Novus
Origene
Chimerigen
Peprotech
Prospec
Aboslute Antibody
Amgen
Abbvie
J & J
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Biogen
UCB
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fusion Protein Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunoglobulin (Ig) Fusion Protein
1.2.3 Parathyroid Hormone (PTH) Fusion Protein
1.2.4 Cytokines Recombinant Fusion Protein
1.2.5 Others
1.3 Market by Application
1.3.1 Global Fusion Protein Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Chimeric Protein Drugs
1.3.3 Biological Technology
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Fusion Protein Therapy Market Perspective (2016-2027)
2.2 Fusion Protein Therapy Growth Trends by Regions
2.2.1 Fusion Protein Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Fusion Protein Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Fusion Protein Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Fusion Protein Therapy Industry Dynamic
2.3.1 Fusion Protein Therapy Market Trends
2.3.2 Fusion Protein Therapy Market Drivers
2.3.3 Fusion Protein Therapy Market Challenges
2.3.4 Fusion Protein Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fusion Protein Therapy Players by Revenue
3.1.1 Global Top Fusion Protein Therapy Players by Revenue (2016-2021)
3.1.2 Global Fusion Protein Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Fusion Protein Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Fusion Protein Therapy Revenue
3.4 Global Fusion Protein Therapy Market Concentration Ratio
3.4.1 Global Fusion Protein Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fusion Protein Therapy Revenue in 2020
3.5 Fusion Protein Therapy Key Players Head office and Area Served
3.6 Key Players Fusion Protein Therapy Product Solution and Service
3.7 Date of Enter into Fusion Protein Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fusion Protein Therapy Breakdown Data by Type
4.1 Global Fusion Protein Therapy Historic Market Size by Type (2016-2021)
4.2 Global Fusion Protein Therapy Forecasted Market Size by Type (2022-2027)
5 Fusion Protein Therapy Breakdown Data by Application
5.1 Global Fusion Protein Therapy Historic Market Size by Application (2016-2021)
5.2 Global Fusion Protein Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Fusion Protein Therapy Market Size (2016-2027)
6.2 North America Fusion Protein Therapy Market Size by Type
6.2.1 North America Fusion Protein Therapy Market Size by Type (2016-2021)
6.2.2 North America Fusion Protein Therapy Market Size by Type (2022-2027)
6.2.3 North America Fusion Protein Therapy Market Size by Type (2016-2027)
6.3 North America Fusion Protein Therapy Market Size by Application
6.3.1 North America Fusion Protein Therapy Market Size by Application (2016-2021)
6.3.2 North America Fusion Protein Therapy Market Size by Application (2022-2027)
6.3.3 North America Fusion Protein Therapy Market Size by Application (2016-2027)
6.4 North America Fusion Protein Therapy Market Size by Country
6.4.1 North America Fusion Protein Therapy Market Size by Country (2016-2021)
6.4.2 North America Fusion Protein Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Fusion Protein Therapy Market Size (2016-2027)
7.2 Europe Fusion Protein Therapy Market Size by Type
7.2.1 Europe Fusion Protein Therapy Market Size by Type (2016-2021)
7.2.2 Europe Fusion Protein Therapy Market Size by Type (2022-2027)
7.2.3 Europe Fusion Protein Therapy Market Size by Type (2016-2027)
7.3 Europe Fusion Protein Therapy Market Size by Application
7.3.1 Europe Fusion Protein Therapy Market Size by Application (2016-2021)
7.3.2 Europe Fusion Protein Therapy Market Size by Application (2022-2027)
7.3.3 Europe Fusion Protein Therapy Market Size by Application (2016-2027)
7.4 Europe Fusion Protein Therapy Market Size by Country
7.4.1 Europe Fusion Protein Therapy Market Size by Country (2016-2021)
7.4.2 Europe Fusion Protein Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Fusion Protein Therapy Market Size (2016-2027)
8.2 Asia-Pacific Fusion Protein Therapy Market Size by Type
8.2.1 Asia-Pacific Fusion Protein Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Fusion Protein Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Fusion Protein Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Fusion Protein Therapy Market Size by Application
8.3.1 Asia-Pacific Fusion Protein Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Fusion Protein Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Fusion Protein Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Fusion Protein Therapy Market Size by Region
8.4.1 Asia-Pacific Fusion Protein Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Fusion Protein Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Fusion Protein Therapy Market Size (2016-2027)
9.2 Latin America Fusion Protein Therapy Market Size by Type
9.2.1 Latin America Fusion Protein Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Fusion Protein Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Fusion Protein Therapy Market Size by Type (2016-2027)
9.3 Latin America Fusion Protein Therapy Market Size by Application
9.3.1 Latin America Fusion Protein Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Fusion Protein Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Fusion Protein Therapy Market Size by Application (2016-2027)
9.4 Latin America Fusion Protein Therapy Market Size by Country
9.4.1 Latin America Fusion Protein Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Fusion Protein Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fusion Protein Therapy Market Size (2016-2027)
10.2 Middle East & Africa Fusion Protein Therapy Market Size by Type
10.2.1 Middle East & Africa Fusion Protein Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Fusion Protein Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Fusion Protein Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Fusion Protein Therapy Market Size by Application
10.3.1 Middle East & Africa Fusion Protein Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Fusion Protein Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Fusion Protein Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Fusion Protein Therapy Market Size by Country
10.4.1 Middle East & Africa Fusion Protein Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Fusion Protein Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Fusion Protein Therapy Introduction
11.1.4 Roche Revenue in Fusion Protein Therapy Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Abnova
11.2.1 Abnova Company Details
11.2.2 Abnova Business Overview
11.2.3 Abnova Fusion Protein Therapy Introduction
11.2.4 Abnova Revenue in Fusion Protein Therapy Business (2016-2021)
11.2.5 Abnova Recent Development
11.3 Novus
11.3.1 Novus Company Details
11.3.2 Novus Business Overview
11.3.3 Novus Fusion Protein Therapy Introduction
11.3.4 Novus Revenue in Fusion Protein Therapy Business (2016-2021)
11.3.5 Novus Recent Development
11.4 Origene
11.4.1 Origene Company Details
11.4.2 Origene Business Overview
11.4.3 Origene Fusion Protein Therapy Introduction
11.4.4 Origene Revenue in Fusion Protein Therapy Business (2016-2021)
11.4.5 Origene Recent Development
11.5 Chimerigen
11.5.1 Chimerigen Company Details
11.5.2 Chimerigen Business Overview
11.5.3 Chimerigen Fusion Protein Therapy Introduction
11.5.4 Chimerigen Revenue in Fusion Protein Therapy Business (2016-2021)
11.5.5 Chimerigen Recent Development
11.6 Peprotech
11.6.1 Peprotech Company Details
11.6.2 Peprotech Business Overview
11.6.3 Peprotech Fusion Protein Therapy Introduction
11.6.4 Peprotech Revenue in Fusion Protein Therapy Business (2016-2021)
11.6.5 Peprotech Recent Development
11.7 Prospec
11.7.1 Prospec Company Details
11.7.2 Prospec Business Overview
11.7.3 Prospec Fusion Protein Therapy Introduction
11.7.4 Prospec Revenue in Fusion Protein Therapy Business (2016-2021)
11.7.5 Prospec Recent Development
11.8 Aboslute Antibody
11.8.1 Aboslute Antibody Company Details
11.8.2 Aboslute Antibody Business Overview
11.8.3 Aboslute Antibody Fusion Protein Therapy Introduction
11.8.4 Aboslute Antibody Revenue in Fusion Protein Therapy Business (2016-2021)
11.8.5 Aboslute Antibody Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Fusion Protein Therapy Introduction
11.9.4 Amgen Revenue in Fusion Protein Therapy Business (2016-2021)
11.9.5 Amgen Recent Development
11.10 Abbvie
11.10.1 Abbvie Company Details
11.10.2 Abbvie Business Overview
11.10.3 Abbvie Fusion Protein Therapy Introduction
11.10.4 Abbvie Revenue in Fusion Protein Therapy Business (2016-2021)
11.10.5 Abbvie Recent Development
11.11 J & J
11.11.1 J & J Company Details
11.11.2 J & J Business Overview
11.11.3 J & J Fusion Protein Therapy Introduction
11.11.4 J & J Revenue in Fusion Protein Therapy Business (2016-2021)
11.11.5 J & J Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Details
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Fusion Protein Therapy Introduction
11.12.4 Bristol-Myers Squibb Revenue in Fusion Protein Therapy Business (2016-2021)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Fusion Protein Therapy Introduction
11.13.4 Novartis Revenue in Fusion Protein Therapy Business (2016-2021)
11.13.5 Novartis Recent Development
11.14 Merck
11.14.1 Merck Company Details
11.14.2 Merck Business Overview
11.14.3 Merck Fusion Protein Therapy Introduction
11.14.4 Merck Revenue in Fusion Protein Therapy Business (2016-2021)
11.14.5 Merck Recent Development
11.15 Alexion Pharmaceuticals
11.15.1 Alexion Pharmaceuticals Company Details
11.15.2 Alexion Pharmaceuticals Business Overview
11.15.3 Alexion Pharmaceuticals Fusion Protein Therapy Introduction
11.15.4 Alexion Pharmaceuticals Revenue in Fusion Protein Therapy Business (2016-2021)
11.15.5 Alexion Pharmaceuticals Recent Development
11.16 Takeda
11.16.1 Takeda Company Details
11.16.2 Takeda Business Overview
11.16.3 Takeda Fusion Protein Therapy Introduction
11.16.4 Takeda Revenue in Fusion Protein Therapy Business (2016-2021)
11.16.5 Takeda Recent Development
11.17 Biogen
11.17.1 Biogen Company Details
11.17.2 Biogen Business Overview
11.17.3 Biogen Fusion Protein Therapy Introduction
11.17.4 Biogen Revenue in Fusion Protein Therapy Business (2016-2021)
11.17.5 Biogen Recent Development
11.18 UCB
11.18.1 UCB Company Details
11.18.2 UCB Business Overview
11.18.3 UCB Fusion Protein Therapy Introduction
11.18.4 UCB Revenue in Fusion Protein Therapy Business (2016-2021)
11.18.5 UCB Recent Development
11.18 Eli Lilly and Company
.1 Eli Lilly and Company Company Details
.2 Eli Lilly and Company Business Overview
.3 Eli Lilly and Company Fusion Protein Therapy Introduction
.4 Eli Lilly and Company Revenue in Fusion Protein Therapy Business (2016-2021)
.5 Eli Lilly and Company Recent Development
11.20 AstraZeneca
11.20.1 AstraZeneca Company Details
11.20.2 AstraZeneca Business Overview
11.20.3 AstraZeneca Fusion Protein Therapy Introduction
11.20.4 AstraZeneca Revenue in Fusion Protein Therapy Business (2016-2021)
11.20.5 AstraZeneca Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Fusion Protein Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunoglobulin (Ig) Fusion Protein
Table 3. Key Players of Parathyroid Hormone (PTH) Fusion Protein
Table 4. Key Players of Cytokines Recombinant Fusion Protein
Table 5. Key Players of Others
Table 6. Global Fusion Protein Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Fusion Protein Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Fusion Protein Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Fusion Protein Therapy Market Share by Regions (2016-2021)
Table 10. Global Fusion Protein Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Fusion Protein Therapy Market Share by Regions (2022-2027)
Table 12. Fusion Protein Therapy Market Trends
Table 13. Fusion Protein Therapy Market Drivers
Table 14. Fusion Protein Therapy Market Challenges
Table 15. Fusion Protein Therapy Market Restraints
Table 16. Global Fusion Protein Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Fusion Protein Therapy Market Share by Players (2016-2021)
Table 18. Global Top Fusion Protein Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fusion Protein Therapy as of 2020)
Table 19. Ranking of Global Top Fusion Protein Therapy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Fusion Protein Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Fusion Protein Therapy Product Solution and Service
Table 23. Date of Enter into Fusion Protein Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Fusion Protein Therapy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Fusion Protein Therapy Revenue Market Share by Type (2016-2021)
Table 27. Global Fusion Protein Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Fusion Protein Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Fusion Protein Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Fusion Protein Therapy Revenue Market Share by Application (2016-2021)
Table 31. Global Fusion Protein Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Fusion Protein Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Fusion Protein Therapy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Fusion Protein Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Fusion Protein Therapy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Fusion Protein Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Fusion Protein Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Fusion Protein Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Fusion Protein Therapy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Fusion Protein Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Fusion Protein Therapy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Fusion Protein Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Fusion Protein Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Fusion Protein Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Fusion Protein Therapy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Fusion Protein Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Fusion Protein Therapy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Fusion Protein Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Fusion Protein Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Fusion Protein Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Fusion Protein Therapy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Fusion Protein Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Fusion Protein Therapy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Fusion Protein Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Fusion Protein Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Fusion Protein Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Fusion Protein Therapy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Fusion Protein Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Fusion Protein Therapy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Fusion Protein Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Fusion Protein Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Fusion Protein Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Fusion Protein Therapy Product
Table 66. Roche Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Abnova Company Details
Table 69. Abnova Business Overview
Table 70. Abnova Fusion Protein Therapy Product
Table 71. Abnova Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 72. Abnova Recent Development
Table 73. Novus Company Details
Table 74. Novus Business Overview
Table 75. Novus Fusion Protein Therapy Product
Table 76. Novus Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 77. Novus Recent Development
Table 78. Origene Company Details
Table 79. Origene Business Overview
Table 80. Origene Fusion Protein Therapy Product
Table 81. Origene Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 82. Origene Recent Development
Table 83. Chimerigen Company Details
Table 84. Chimerigen Business Overview
Table 85. Chimerigen Fusion Protein Therapy Product
Table 86. Chimerigen Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 87. Chimerigen Recent Development
Table 88. Peprotech Company Details
Table 89. Peprotech Business Overview
Table 90. Peprotech Fusion Protein Therapy Product
Table 91. Peprotech Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 92. Peprotech Recent Development
Table 93. Prospec Company Details
Table 94. Prospec Business Overview
Table 95. Prospec Fusion Protein Therapy Product
Table 96. Prospec Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 97. Prospec Recent Development
Table 98. Aboslute Antibody Company Details
Table 99. Aboslute Antibody Business Overview
Table 100. Aboslute Antibody Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 101. Aboslute Antibody Recent Development
Table 102. Amgen Company Details
Table 103. Amgen Business Overview
Table 104. Amgen Fusion Protein Therapy Product
Table 105. Amgen Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 106. Amgen Recent Development
Table 107. Abbvie Company Details
Table 108. Abbvie Business Overview
Table 109. Abbvie Fusion Protein Therapy Product
Table 110. Abbvie Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 111. Abbvie Recent Development
Table 112. J & J Company Details
Table 113. J & J Business Overview
Table 114. J & J Fusion Protein Therapy Product
Table 115. J & J Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 116. J & J Recent Development
Table 117. Bristol-Myers Squibb Company Details
Table 118. Bristol-Myers Squibb Business Overview
Table 119. Bristol-Myers Squibb Fusion Protein Therapy Product
Table 120. Bristol-Myers Squibb Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 121. Bristol-Myers Squibb Recent Development
Table 122. Novartis Company Details
Table 123. Novartis Business Overview
Table 124. Novartis Fusion Protein Therapy Product
Table 125. Novartis Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 126. Novartis Recent Development
Table 127. Merck Company Details
Table 128. Merck Business Overview
Table 129. Merck Fusion Protein Therapy Product
Table 130. Merck Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 131. Merck Recent Development
Table 132. Alexion Pharmaceuticals Company Details
Table 133. Alexion Pharmaceuticals Business Overview
Table 134. Alexion Pharmaceuticals Fusion Protein Therapy Product
Table 135. Alexion Pharmaceuticals Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 136. Alexion Pharmaceuticals Recent Development
Table 137. Takeda Company Details
Table 138. Takeda Business Overview
Table 139. Takeda Fusion Protein Therapy Product
Table 140. Takeda Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 141. Takeda Recent Development
Table 142. Biogen Company Details
Table 143. Biogen Business Overview
Table 144. Biogen Fusion Protein Therapy Product
Table 145. Biogen Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 146. Biogen Recent Development
Table 147. UCB Company Details
Table 148. UCB Business Overview
Table 149. UCB Fusion Protein Therapy Product
Table 150. UCB Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 151. UCB Recent Development
Table 152. Eli Lilly and Company Company Details
Table 153. Eli Lilly and Company Business Overview
Table 154. Eli Lilly and Company Fusion Protein Therapy Product
Table 155. Eli Lilly and Company Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 156. Eli Lilly and Company Recent Development
Table 157. AstraZeneca Company Details
Table 158. AstraZeneca Business Overview
Table 159. AstraZeneca Fusion Protein Therapy Product
Table 160. AstraZeneca Revenue in Fusion Protein Therapy Business (2016-2021) & (US$ Million)
Table 161. AstraZeneca Recent Development
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fusion Protein Therapy Market Share by Type: 2020 VS 2027
Figure 2. Immunoglobulin (Ig) Fusion Protein Features
Figure 3. Parathyroid Hormone (PTH) Fusion Protein Features
Figure 4. Cytokines Recombinant Fusion Protein Features
Figure 5. Others Features
Figure 6. Global Fusion Protein Therapy Market Share by Application: 2020 VS 2027
Figure 7. Chimeric Protein Drugs Case Studies
Figure 8. Biological Technology Case Studies
Figure 9. Others Case Studies
Figure 10. Fusion Protein Therapy Report Years Considered
Figure 11. Global Fusion Protein Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Fusion Protein Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Fusion Protein Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global Fusion Protein Therapy Market Share by Regions (2022-2027)
Figure 15. Global Fusion Protein Therapy Market Share by Players in 2020
Figure 16. Global Top Fusion Protein Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fusion Protein Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Fusion Protein Therapy Revenue in 2020
Figure 18. Global Fusion Protein Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global Fusion Protein Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Fusion Protein Therapy Market Share by Type (2016-2027)
Figure 22. North America Fusion Protein Therapy Market Share by Application (2016-2027)
Figure 23. North America Fusion Protein Therapy Market Share by Country (2016-2027)
Figure 24. United States Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Fusion Protein Therapy Market Share by Type (2016-2027)
Figure 28. Europe Fusion Protein Therapy Market Share by Application (2016-2027)
Figure 29. Europe Fusion Protein Therapy Market Share by Country (2016-2027)
Figure 30. Germany Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Fusion Protein Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Fusion Protein Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Fusion Protein Therapy Market Share by Region (2016-2027)
Figure 40. China Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Fusion Protein Therapy Market Share by Type (2016-2027)
Figure 48. Latin America Fusion Protein Therapy Market Share by Application (2016-2027)
Figure 49. Latin America Fusion Protein Therapy Market Share by Country (2016-2027)
Figure 50. Mexico Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Fusion Protein Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Fusion Protein Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Fusion Protein Therapy Market Share by Country (2016-2027)
Figure 56. Turkey Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Fusion Protein Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 60. Abnova Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 61. Novus Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 62. Origene Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 63. Chimerigen Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 64. Peprotech Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 65. Prospec Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 66. Aboslute Antibody Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 67. Amgen Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 68. Abbvie Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 69. J & J Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 70. Bristol-Myers Squibb Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 71. Novartis Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 72. Merck Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 73. Alexion Pharmaceuticals Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 74. Takeda Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 75. Biogen Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 76. UCB Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 77. Eli Lilly and Company Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 78. AstraZeneca Revenue Growth Rate in Fusion Protein Therapy Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界の融合タンパク質市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Fusion Protein Market The global Fusion Protein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…- 世界のキメラ融合タンパク質市場規模・現状・予測（2021年-2027年） Chimeric fusion proteins, produced by genetic engineering, are currently made up of effector peptides, for example, a ligand-binding portion of a cytokine or growth factor, extracellular domains of lymphocyte antigens, or a toxin linked to a suitable fusion partner. Market Analysis and Insights: Glo…
- 世界のキメラ融合タンパク質市場規模・現状・予測（2021年-2027年） Chimeric fusion proteins, produced by genetic engineering, are currently made up of effector peptides, for example, a ligand-binding portion of a cytokine or growth factor, extracellular domains of lymphocyte antigens, or a toxin linked to a suitable fusion partner. Market Analysis and Insights: Glo…
- 世界の組換えタンパク質市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Recombinant Protein Market The global Recombinant Protein market size is projected to reach US$ 1062 million by 2026, from US$ 612 million in 2019, at a CAGR of 8.1% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…
- 世界の骨形成タンパク質（BMP）2市場規模・現状・予測（2021年-2027年） Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenanc…